The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder
Abstract
The objective of the study was to investigate the association of blood glucose and lipid profile parameters with cognitive impairment in schizophrenia. A total of 200 schizophrenia patients and 169 controls were enrolled in the study. Blood glucose and lipid profile were estimated in all the subjects. Cognition was assessed using Addenbrooke cognitive examination-III (ACE-III). Fasting glucose (p ≤ .001) and triacylglycerol (p = .018) were increased and HDL-Cholesterol (p ≤ .001), was reduced in schizophrenia. Glucose (r = −0.158, p = .026), total cholesterol (r = −0.249, p = .0001) and triacylglycerol (r = −0.168, p = .018) was negatively correlated with total ACE III score. Triacylglycerol (p = .041) was elevated in cases with mild cognitive impairment. Plasma glucose, total cholesterol and triacylglycerol were associated with various cognitive domains suggesting that hyperglycaemia and hyperlipidaemia might increase the risk of cognitive impairment in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum lipid profiles may, therefore, serve as indicators for evaluating SCZ symptoms (30,31).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [31]
In the citing paper
“Nandeesha (2023) [52] showed that total cholesterol (TC) and TG levels were negatively correlated with cognitive scores.”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [52]
In the citing paper
“High-density lipoprotein (HDL) was decreased in two studies [51,52].”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [52]
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Sagar, R., Dandona, R., Gururaj, G., Dhaliwal, R. S., Singh, A., Ferrari, A., Dua, T., Ganguli, A., Varghese, M., Chakma, J. K., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30475-4 · Cited by 886
Cognition and synaptic plasticity in diabetes mellitus
Gispen, W. H., & Biessels, G.-J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01656-8 · Cited by 772
Impact of diabetes on cognitive function and brain structure
Moheet, A., Mangia, S., & Seaquist, E. R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12807 · Cited by 510
Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439
(2007) · PubMed · Cited by 324
Neurodevelopmental origin of cognitive impairment in schizophrenia
Bora, E. (2015) · Psychological Medicine · doi:10.1017/s0033291714001263 · Cited by 221
Validation of the Friedewald formula in patients with metabolic syndrome
Knopfholz, J., Disserol, C. C. D., Pierin, A. J., Schirr, F. L., Streisky, L., Takito, L. L., Massucheto Ledesma, P., Faria-Neto, J. R., Olandoski, M., da Cunha, C. L. P., et al. (2014) · Cholesterol · doi:10.1155/2014/261878 · Cited by 196
Research works printed but not linked: 3
- 10.3109/10401230109148955 · doi:10.3109/10401230109148955
- Jimenez, M.A. and Guerrero, J.L.G., 2017. Disorders associated with mild cognitive impairment. Risk factors and predictors. Revista espanola de geriatria y gerontologia, 52, 20–23.
- Krug, A. and Kircher, T., 2017. Cognitive disorders in schizophrenia. Fortschritte der neurologie-psychiatrie, 85 (5), 292–304.
Cited by
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Huang, J.-K., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084300 · Cited by 130
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36
Qiu, Y., Li, S., Teng, Z., Tan, Y., Xu, X., Yang, M., Zhao, Z., Liu, J., Tang, H., Xiang, H., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.100 · Cited by 21
Couttas, T. A., Jieu, B., Rohleder, C., & Leweke, F. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.885904 · Cited by 21
(2024) · doi:10.3389/fpsyt.2024.1442954 · Cited by 15
Metadata
- Authors
- Nandeesha, H., Keshri, N., Rajappa, M., & Menon, V.
- Affiliations
- Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
- Corresponding author
- Nandeesha, Hanumanthappa
- Venue
- Archives of Physiology and Biochemistry
- Publisher
- Informa UK Limited
- Published
- 2020-11-03
- Volume
- 129
- Issue
- 2
- Pages
- 497-504
- ISSN
- 0778-3124 (ISSN-L)
- 1381-3455
- 1744-4160
- OpenAlex
- W3095213654
- Cited by
- 17
- References
- 32
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.org/10.1080/policies-text-data-mining (tdm)
- Locations
- Archives of Physiology and Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- JIPMER
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- schizophrenia, cognitive impairment, hyperglycemia, hyperlipidemia, fasting blood glucose, lipid profile, triglycerides, total cholesterol, HDL cholesterol, mild cognitive impairment, schizophrenia spectrum disorders
- MeSH terms
- Blood Glucose, Glucose, Humans, Hyperglycemia, Hyperlipidemias, Cholesterol, HDL, Schizophrenia, Triglycerides, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder. https://app.cochat.ai/papers/10.1080/13813455.2020.1839500
- The paper
- Nandeesha, H., Keshri, N., Rajappa, M., & Menon, V. (2023). Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder. Archives of Physiology and Biochemistry. https://doi.org/10.1080/13813455.2020.1839500
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.